210 lines
9.0 KiB
Standard ML
210 lines
9.0 KiB
Standard ML
by: William Mann MD
|
|
Univ of North Dakota School of Medicine
|
|
|
|
|
|
|
|
PREMENSTRUAL SYNDROME
|
|
|
|
Case History
|
|
|
|
An unemployed nulliparous 19-year-old woman was arrested for stabbing
|
|
her boyfriend while intoxicated. Menarche was at 13 years, and she had
|
|
been well with no behavioral problem until l5, when she began to
|
|
exhibit paroxysmal aberrant behavior including: slashing her wrists,
|
|
shoplifting, arson, promiscuity, alcohol intoxication, expulsion from
|
|
school for assaulting teachers, and mutilation of her hands and feet
|
|
with cuts and cigarette burns. In prison, prior to her next four
|
|
menstrual periods, she assaulted a guard, tried to hang herself, cut her
|
|
wrists, and attempted to escape. During the rest of her cycle, she was
|
|
cooperative, rational, and penitent. All past episodes of aberrant
|
|
behavior which could be accurately dated, occurred on a cycle length of
|
|
29+- 2.5 days.
|
|
|
|
|
|
Initially in prison she was treated with Chlorpromazine 100mg bid and
|
|
fluphenazine injections 20 mg every 10 days. She stated that she felt
|
|
a little calmer, but depressed, with continued cyclic suicidal impulses
|
|
and a wish to "escape from life". On several occasions during the
|
|
premenstruum she requested that she be locked up alone and expressed
|
|
fear that she was going to lose control.
|
|
|
|
She was started on medroxyprogesterone 10 mg qd on day 22 of each cycle,
|
|
and for the past two years has been free of premenstrual behavior
|
|
changes, with only mild symptoms of restlessness and bloating. She is
|
|
now working full time and married.
|
|
|
|
Definition
|
|
|
|
Premenstrual Syndrome is any combination of symptoms and signs occurring
|
|
cyclically prior to menses and resolving with the onset of menses.
|
|
|
|
Clinical Presentation
|
|
|
|
Subjective
|
|
|
|
The commonest symptoms are related to mood; - depression, irritability,
|
|
tension, lability, lassitude, insomnia and impulsivity; to body fluid
|
|
changes; - edema, weight gain, abdominal bloating, and breast fullness;
|
|
and to physical discomfort - headache, breast pain, abdominal pain or
|
|
generalized physical dysphoria.
|
|
|
|
Polydipsia, polyphagia, diarrhea and acne are also common.
|
|
Pre-existing physical and emotional problems may be exacerbated.
|
|
|
|
Objective
|
|
|
|
Weight gain is common, but so is weight loss, and affect changes may be
|
|
apparent in familiar patients. Laboratory investigations are not
|
|
generally helpful.
|
|
|
|
Clinical Management
|
|
|
|
Assessment
|
|
|
|
Almost all women report some premenstrual symptoms. It is essential to
|
|
differentiate between those who find their symptoms tolerable, and
|
|
those who consider themselves ill and who have distressing symptoms and
|
|
impaired functional capacity. It is also important to assess any
|
|
exacerbation of ongoing health problems. The specific symptoms most
|
|
troublesome to the patient and their severity guide rational therapy.
|
|
|
|
Mechanisms
|
|
|
|
The large number of theoretical models of the biochemical basis of PMS
|
|
reflect the fragile, incomplete understanding of the problem and the
|
|
complexity of its causative mechanisms. Likewise, the large number of
|
|
recommended treatments, none of which are consistently effective,
|
|
suggest a multiplicity of mechanisms with variable expression from
|
|
patient to patient. In general terms, PMS seems to represent protean
|
|
manifestations of psycho-neuro-endocrine flux, or dysfunction in the
|
|
cycling of the hypothalamic-pituitary-ovarian axis. Particular
|
|
symptoms suggest a role for specific mediators and provide some
|
|
rationale for management of individual cases.
|
|
|
|
|
|
Estrogen effects sodium and water retention, and in addition alters the
|
|
metabolism of plasma renin and angiotesin II with a resultant increase
|
|
in Aldosterone
|
|
|
|
Progesterone has a natriuretic effect, but also increases aldosterone
|
|
activity. PMS symptoms do not occur when physiologic progesterone
|
|
levels are low in the pre-ovulatory phase and anovulatory cycles.
|
|
Paradoxically, progesterone frequently is effective treatment.
|
|
Although excreted levels of estrogren and progesterone are not
|
|
measurably abnormal, an imbalance of estrogen/progesterone is a
|
|
currently favored hypothesis. Further confusing this is the
|
|
observation that as many patients are made worse as are made better
|
|
with OCs.
|
|
|
|
Prolactin and vasopressin secretion may play a role in breast and fluid
|
|
balance changes, and although plasma levels have not correlated with
|
|
symptoms, normal bromocriptine has been beneficial, as have ergot
|
|
alkaloids.
|
|
|
|
Changes in central catecholamines (dopamine, norepinephrine, and
|
|
epinephrine) may play a role in affective and fluid balance changes.
|
|
|
|
The measurable changes in other pituitary products - alpha MSH,GH,LH,
|
|
FSH and Beta endorphin - which occur premenstrually probably contribute
|
|
to the complexity of PMS.
|
|
|
|
Numerous clinical therapeutic trials have been provoked by such
|
|
possible causal associations as Vitamin B6 with abnormal tryptophan
|
|
metabolism and estrogen metabolism, by the anti-estrogenic effect of
|
|
Vitamin A, and its effect on acne, by possible allergy to endogenous
|
|
progresterone, and by catharsis as a means of eliminating fluid and
|
|
unspecified toxin in constipated patients.
|
|
|
|
Plans
|
|
|
|
The goal of therapy is to reduce symptoms to a level which is tolerable
|
|
to the patient and which does not impair her function. Treatment
|
|
should be aimed at the specifically troublesome symptoms, and frequent
|
|
follow up should gauge the effect on these symptoms and the patient's
|
|
improvement in function. Treatment should be carefully matched to the
|
|
patient's distress, as many suggested therapies have significant
|
|
toxicity.
|
|
|
|
Documented weight gain can be rationally approached with spironolactone
|
|
25-50 mg b-tid, and if this fails, hydrochlorothiazide, 25-50 mg qd.
|
|
|
|
Headache, mastalgia, and generalized discomfort may be relieved with
|
|
mild analgesics, and NSAIDs may be particularly useful with patients
|
|
who also suffer from dysmenorrhea.
|
|
|
|
Non-specific measures such as local heat, rest, and sodium restriction
|
|
may be helpful, as may exercise and weight loss which, in theory, may
|
|
have a beneficial effect on estrogen metabolism.
|
|
|
|
In patients with sleep disturbance and depression, tricyclics and
|
|
occasionally lithium may be indicated.
|
|
|
|
Bellergal, a combination of ergot, phenobarbitol, and belladonna, is a
|
|
non-specific but frequently useful treatment for patients with
|
|
irritability, breast tenderness, and abdominal bloating. Except in low
|
|
dose for occasional use, tranquilizers are best avoided as they are
|
|
entirely non-specific, even though they will reduce any patient's
|
|
complaints about most symptoms.
|
|
|
|
Medroxy progesterone 10 mg daily during the symptomatic days, and
|
|
progesterone suppositories are very frequently effective. The estrogen
|
|
antagonist methyltestosterone is very effective, but rarely, if ever,
|
|
indicated. Bromocriptine counteracts the osmoregulatory actions and
|
|
breast stimulation of prolactin, but also has numerous poorly
|
|
understood actions in the pituitary hyopthalamus and basal ganglia.
|
|
|
|
Follow Up
|
|
|
|
The fine adjustment of treatment against symptoms can generally be
|
|
achieved in a few monthly visits.
|
|
|
|
|
|
Education
|
|
|
|
Explanation that PMS is not pathologic, accompanied by support from the
|
|
physician and from acquaintances with PMS is very helpful. The patient
|
|
should understand the goals of treatment and be given the
|
|
responsibility for adjustment of therapy.
|
|
|
|
Epidmiology
|
|
|
|
Most women suffer some symptoms of PMS, and at least a third report
|
|
significant incapacity. Psychiatric disturbance, crime and accidents
|
|
are more frequent during the premenstrual period but still less
|
|
frequent than the noncycling base line for males. The data, then, may
|
|
suggest that women deteriorate toward the male level of functioning
|
|
during the premenstrual period, or conversely that women have a
|
|
syndrome of functional improvement during the rest of the cycle, with
|
|
fewer seizures, fewer symptoms, less aberrant behavior, increased
|
|
energy and self-esteem, and improved mood.
|
|
|
|
Costs
|
|
|
|
The very significant costs of functional disability, interpersonal
|
|
discord, and personal distress may be greatly ameliorated with
|
|
education, support, and carefully adjusted symptomatic treatment.
|
|
|
|
Learning Issues
|
|
|
|
In managing a problem with no consistent physical signs or laboratory
|
|
abnormalities, it is essential to make an accurate assessment of the
|
|
patient's function and symptomatic distress, to tailor treatment to
|
|
these, and to set and move toward appropriate goals together with the
|
|
patient.
|
|
|
|
|
|
|
|
References
|
|
|
|
Premenstrual Syndrome, Editorial; Lancet; December 1981, 1393-94.
|
|
|
|
Reid, R.L. and Yen, S.S.C. Premenstrual Syndrome; American Journal of
|
|
Obstetrics and Gynecology; 139; 85-104. 1981.
|
|
|
|
Elsner, C.W., et.al. Bromocriptine in the Treatment of Premenstrual
|
|
Tension Syndrome, Obstetrics and Gynecology; 56, 6; 723-26. 1980.
|
|
in the pre-ovulatory phase and anovulatory cycles.
|
|
Paradoxically, progesterone frequently is effective treatment.
|
|
Although excreted levels of estrogren and progesterone are not
|
|
measurably abnormal, an imbalance of estrogen/progesterone is a
|
|
currently f |